The 2-(silyloxymethyl)allylboration of aldehydes was established to enable stereoselective access to a-(exo)-methylene g-butyrolactones under mild conditions. Acid-labile functionality and chiral carbonyl compounds are tolerated. Excellent asymmetric induction was observed for b,b 0 -disubstituted a,b-epoxy aldehydes. These findings led to the enantioselective total synthesis of the sesquiterpene natural product (À)-parthenolide, its unnatural (+)-enantiomer, and diastereoisomers. Among all the isomers tested in cell culture, only (À)-parthenolide showed potent inhibition of microtubule detyrosination in living cells, confirming its exquisite selectivity on tubulin carboxypeptidase activity. On the other hand, the antiinflammatory activity of the parthenolides was weaker and less selective with regard to compound stereochemistry.
Introduction a-(exo)-Methylene g-butyrolactones (aMgBs) contribute to the biological activity of more than 5000 natural products.
1 Many of these show interesting potential in chemical biology and drug development.
1,2 A prominent aMgB natural product is the sesquiterpenoid (À)-parthenolide (1), 3 an anti-inammatory natural product from feverfew (Tanacetum parthenium) that induces apoptosis in cancer (stem) cells. 4 Its mode of action is complex and features inhibition of NF-kB activation, 5 alteration of DNA methylation, 6 induction of oxidative stress, 7 and inhibition of tubulin carboxypeptidase (TCP) activity. 8 The latter has become a highly important focus for neuroregeneration 8c,d,9 and heart failure treatment research. 10 Importantly, TCP has only recently been identied on the genetic level 8d, 11 and its activation and regulation are still difficult to study. Tool compounds with specic activity on TCP would have signicant importance for medical research and potentially drug development. In this regard, for enabling thorough studies of parthenolide, a fully stereocontrolled de novo synthesis of the natural product was sought that is based on exchangeable building blocks and provides liberal access to stereoisomers for studying target selectivity. Previously reported syntheses of parthenolide did not allow a comprehensive study (Scheme 1). Chen and co-workers employed the linear epoxy aldehyde 2a,b and an intramolecular, non-diastereoselective Nozaki-Hiyama-Kishi allylation (a), followed by (Z / E) isomerization of the internal alkene. 12 The lactone was obtained aer aminolysis of the nitrile and refunctionalization (d) . A second synthesis featured an aldol addition of chiral camphorsultam derivative 4a,b to a,bunsaturated aldehyde 3 (a), leading to a separable product mixture. 13 Refunctionalization, intramolecular alkylation (b) hydroxyl-directed epoxidation and oxidative lactonization (d) gave 1. Recently, Liu and co-workers reported a racemic parthenolide synthesis 14 based on Still's ring enlarging oxy-Cope rearrangement of 1,5-diene (AE)-5 (b), followed by (Z / E) isomerization of an internal alkene.
15 a-Alkylation of the resulting ketone with ethyl bromoacetate (6, c), reduction, epoxidation, oxidative lactonization (d) and a-methylenation (7) completed the synthesis. Additionally, syntheses of parthenolide's natural precursor costunolide (8) were described, 16 from which parthenolide is available. 17 Various syntheses leading to diastereomers of the natural product have been reported as well. In order to realize a modular, enantioselective, and stereocontrolled synthesis, we envisioned to use an intramolecular sulfone allylation to close the ten-membered ring (Scheme 1, bottom). 13, 19 Precursor 9 already contains the epoxide motif and is geared for late stage oxidative lactonization to form the reactive aMgB. 17,18b Several indirect as well as direct syntheses of aMgBs have been reported. 1a,b Among them, allylboration methods offered predictable high stereoselectivity, 1b,20 which has been a major challenge in previous parthenolide syntheses. Accordingly, diastereoselective allylboration directed by the epoxide's and the boronate's stereochemistry, simplies sulfone 2 to the chiral a,b-epoxy aldehyde 10 and the novel 2-(silyloxymethyl)allylboronate (Z)-11a. The epoxide group was expected to provide 1,2-asymmetric induction, 21 but its level and its sense (Felkin or anti-Felkin) were not clear for these unknown allylboronates at the onset of our studies. However, by using either enantiomer of the epoxy aldehyde, and additionally epoxide inversion, any desired stereoisomer should be obtained (see also Scheme 5 below).
12,18
Moreover, by design, the allylboronate 11a should operate as a "linchpin" reagent for aMgB synthesis in general. Being electron rich, it was expected to display intrinsically high allylation rates and to reliably install the trans conguration of the aMgB (/1). 20 Hence, these allylboronates should allow allylboration-based aMgB synthesis from acid labile carbonyl compounds such as aldehyde 10. These substrates are incomepatible with 2-(alkoxycarbonyl)allylboration reagents that demand activation by either Lewis/Brønsted acids or elevated temperature. 20, 22 Hence, a signicant scope and broader applicability were expected for these new allyl boronates.
Results and discussion
To explore the scope and feasibility of this approach and the utility of the reagents envisioned, we prepared the pseudo-trans congured (Z)-2-(silyloxymethyl)allylboronates (Z)-11a-c (Scheme 2) starting from 2-butyne-1,4-diol (12) by using a combination of syn-selective hydrostannylation 23 and regioselective functionalization to obtain the versatile alkenyl halide 15 (50% yield, 6 steps). Introduction of a desired side chain by nucleophilic substitution, followed by a Negishi coupling with Knochel's IZnCH 2 B(pin) reagent 24 allowed then the stereo-and regioselective preparation of the stable 2-(silyloxymethyl)allylboronates (Z)-11a-c in good yields (Scheme 2).
Next, reagents (Z)-11a-c were investigated for allylboration of achiral aldehydes and chiral a,b-epoxy carbonyl compounds (for their preparation see the ESI †), where focus was placed on acidlabile features (Scheme 3). Gratifyingly, allylboration proceeded cleanly between 0 and 25 C without the addition of external acidic activators. In fact, buffering by using solid NaHCO 3 was found essential to obtain reproducible yields, especially for more labile aldehydes. Hence, the excellent stereocontrol of these novel allylboronates could be exploited for the synthesis of 4,5-dia-parthenolide (22). By using a late stage epoxide inversion, the natural parthenolide (1) could be synthesized. Consequently, the allylboration product (+)-16g (92% ee) was cleanly protected with a TBS group (/(+)-17, Scheme 4) at low temperature, to suppress (Lewis-) acid induced epimerization. Chemoselective oxidation of the thioether gave the sulfone (+)-18. The PMB ether of 18 was cleaved by treatment with DDQ in a quaternary aqueous solvent mixture, which drastically reduced the reaction time and reagent amount needed, compared to common biphasic mixtures. Aer work up with NaBH 4 (to reduce some enal byproduct formed), the allylic alcohol obtained was transformed into the allylic bromide (À)-9 by mesylation and in situ substitution with LiBr (82% over 2 steps). Structure and relative conguration of (AE)-9 were veried by single-crystal X-ray analysis (see the ESI †). Closure of the tenmembered ring was then achieved by intramolecular substitution. Optimized conditions featured addition of the sulfone 9 to excess KHMDS at 0 C in THF at a nal dilution of 4 mM, giving rise to the separable sulfone diastereomers 19a,b. The yield of this challenging transformation was somewhat scale dependent. Under optimized conditions the reaction could be performed on viable scale (100 mg) in high yield (80% Twofold O-TBS deprotection (Scheme 5) of germacrane 20 then gave the labile epoxy diol (+)-21 that was immediately Epoxidation with opposite stereochemistry was achieved aer twofold TBS group removal (TBAF) and directed Sharpless epoxidation (4.1 : 1 dr, 74% yield), unfortunately without signicant inuence of the ligand's stereochemistry on the reaction stereoselectivity, in line with earlier reports for similar transformations.
14,18b The labile epoxy diol (À)-24 thus obtained was oxidized to the aMgB to provide (+)-parthenolide [(4S,5S,6R,7R)-1] in 72% yield. Alternatively, chiral HPLC separation of racemic (AE)-1 provided both enantiomers of natural parthenolide. The (À)-form [(4R,5R,6S,7S)-1] was identical with an authentic sample.
Parthenolide has been associated with a variety of biological activities, which may be specic or unspecic, as aMgBs are fairly reactive electrophiles.
2a,30 A hallmark of TCP activity, which was of special interest, is the modulation of tyrosinated tubulin in living cells.
8d, 31 As a relevant model, we primarily chose to test how parthenolide's stereochemistry inuences microtubule detyrosination in axonal growth cones of primary sensory neurons. It was previously shown that inhibition of microtubules detyrosination by parthenolide in a low concentration range of 0.5-5 nM markedly promotes microtubule dynamics and axon growth of cultured sensory neurons, thereby accelerating axonal growth.
8 It, therefore, mimics the benecial effects of constitutively active glycogen synthase kinase 3 (GSK3) on nerve regeneration by modulating microtubule detyrosination via MAP1B activation.
8b However, parthenolide loses its benecial effect on axon growth in vitro again at higher concentrations and even reduces axon growth at very high concentrations.
8 This is because a strong inhibition of detyrosination rather destabilizes microtubules and subsequently axon extension.
8 Previous work with costunolide and parthenolide indicated that parthenolide's Michael acceptor and the epoxide group are both crucial for the activity observed.
8a
In order to gain a deeper understanding of the target selectivity, we compared natural parthenolide derived from feverfew to synthetic (À)-1, (+)-1, (À)-22, and (+)-22 in mouse primary cell culture (Fig. 1) . Both natural parthenolide and synthetic (À)-1 inhibited detyrosination of microtubules in axonal growth cones at 1 nM to a similar degree, while (+)-1 showed a smaller but still considerable effect. Isomers (À)-22 and (+)-22 indicated no signicant activity, also not at higher concentration (not shown). To corroborate this nding, we functionally tested the compounds regarding their concentration-dependent activity on axon growth (Fig. 2) . Again, both natural and synthetic parthenolide [(À)-1] almost equally promoted axon growth of cultured sensory neurons at 0.5 nM and to a stronger extent at 1 nM, when the lengths of regenerated axons were evaluated aer 48 hours in culture ( Fig. 2A and B) . At 5 nM, the benecial effects of native and synthetic parthenolide [(À)-1] were almost abolished, and 50 nM even reduced axon growth, thereby demonstrating a very similar functional prole over different concentrations. In contrast to those compounds, the enantiomer (+)-1 showed a small, but statistically signicant effect only at 1 nM. Interestingly, also at 50 nM, the enantiomer (+)-1 did not reduce axon regeneration. Isomers (À)-22 and (+)-22 showed no signicant increase or decrease in axon growth in the tested concentration range, which is in line with the results from detyrosination experiments.
In order to study the selectivity of parthenolides against TCP activity as a putative target compared to its reported antiinammatory activity, 32 we investigated the anti-inammatory features of natural parthenolide along with the synthetic stereoisomers (À)-1, (+)-1, (À)-22, and (+)-22 in human monocyte-derived macrophages during lipopolysaccharide (LPS)/interferone (INF)-g-induced 48 h polarization into the M1 phenotype. Parthenolide, at low micromolar concentrations, inhibits Ik-B kinase 5b and related expression of cyclooxygenase (COX)-2 and tumor necrosis factor (TNF)-a in LPS-activated macrophages. 33 MTT assays revealed some but no signicant loss of cell viability by the compounds at 10 mM, while at 30 mM all parthenolides displayed signicant cytotoxicity (Fig. 3A) . At 10 mM, PTL suppressed COX-2 expression and TNF-a release, which was more pronounced for synthetic (À)-1 and (+)-1, with (+)-1 being little superior over (À)-1 (Fig. 3B and C) . Of interest, isomers (À)-22 and (+)-22 (10 mM, each) were equally bioactive, and (À)-22 turned out to be the most potent stereoisomer in suppressing COX-2 (Fig. 3B and C) .
In combination, these data show that natural (À)-parthenolide as well as the stereoisomers are not signicantly cytotoxic for macrophages up to 10 mM, but loss of cell viability is evident at 30 mM. These data compare favorably with data obtained earlier for the natural product on neuronal cells.
8b Antiinammatory activity (i.e., suppression of COX-2 and TNF-a) 33 could be conrmed, but somewhat unexpectedly, no marked differences seem to differentiate the stereoisomers. Furthermore, compared to dedicated anti-inammatory agents such as glucocorticoids, the observed activity was generally mild and occurred at levels that are close to the level of cytotoxicity during macrophage (M1) activation. In contrast, bioactivity on neurons is observed at the nM level, three orders of magnitude lower than the anti-inammatory activity against macrophages at non-cytotoxic concentrations (i.e., 10 mM).
For the rst time, these data conrm that the interaction of (À)-parthenolide with the structurally yet uncharacterized tubulin carboxypeptidase target is fairly specic on the molecular level-despite its covalently reactive and potentially indiscriminate aMgB functional group.
30b While further research is denitely necessary, our data may suggest that not only the presence of the epoxide in the parthenolide structure but also its positioning and hence its impact on conformation or reactivity are crucial for this mode of action. Furthermore, we found the activity mediated by TCP modulated at much lower levels of parthenolide (nM) in neuronal cells than anti-inammatory and toxic side effects occurred in macrophages (mM). While these data cannot directly be taken as a measure for therapeutic index, they do indicate that parthenolide may indeed serve as a promising template for developing non-toxic agents for neuroregeneration.
Conclusions
In order to evaluate bioactivity of parthenolide stereoisomers, we have introduced electron-rich (Z)-allylboronates (11) for the stereocontrolled synthesis of a-(exo-)methylene g-butyrolactones from acid labile precursors. For high levels of 1,2-asymmetric induction with a,b-epoxy aldehydes, b,b 0 disubstitution was found to be crucial. For these substrates apparent Felkin-Anh control is operative during allylboration. These developments led to the rst convergent stereoselective total synthesis of (+)-and (À)-parthenolide (1) in 16 steps from geranyl acetate (4.3% overall yield), as well as its stereoisomers. By using these compounds the specicity of the intervention of (À)-parthenolide with microtubule detyrosination and the importance of a specic molecular interaction event when targeting this activity were validated. The synthetic methodology presented herein should facilitate the efficient synthesis of dedicated tubulin carboxypeptidase inhibiting tool compounds, and, in extension, of many other bioactive target compounds containing aMgBs.
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